The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,959.00
Bid: 1,952.00
Ask: 1,954.00
Change: 20.00 (1.03%)
Spread: 2.00 (0.102%)
Open: 1,940.00
High: 1,971.00
Low: 1,940.00
Prev. Close: 1,939.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Four Brokers Raise Close Brothers Price Target

Wed, 12th Mar 2014 10:05

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
BERENBERG CUTS TRAVIS PERKINS PRICE TARGET TO 1800 (1880) PENCE - 'HOLD'
----------
JEFFERIES CUTS LAND SECURITIES TO 'HOLD' ('BUY') - PRICE TARGET 1112 PENCE
----------
JEFFERIES CUTS BRITISH LAND TO 'HOLD' ('BUY')
----------
BERNSTEIN CUTS MORRISON PRICE TARGET TO 220 (270) PENCE - 'MARKET-PERFORM'
----------
CITIGROUP RAISES ASHTEAD GROUP PRICE TARGET TO 1075 (850) PENCE - 'BUY'
----------
GOLDMAN CUTS PERSIMMON TO 'BUY' ('CONVICTION BUY LIST')
----------
MORGAN STANLEY RAISES SHELL PRICE TARGET TO 2500 (2330) PENCE - 'EQUAL-WEIGHT'
----------
MORGAN STANLEY RAISES BP PRICE TARGET TO 525 (490) PENCE - 'EQUAL-WEIGHT'
----------
GOLDMAN RAISES SPORTS DIRECT PRICE TARGET TO 1100 (980) PENCE - 'CL BUY'
----------
CHARLES STANLEY CUTS ADMIRAL GROUP TO 'REDUCE' ('HOLD')
----------
FTSE 250
----------
BERENBERG RAISES CLOSE BROTHERS PRICE TARGET TO 1640 (1330) PENCE - 'BUY'
----------
NUMIS RAISES CLOSE BROTHERS PRICE TARGET TO 1325 (1214) PENCE - 'HOLD'
----------
JPMORGAN RAISES CLOSE BROTHERS PRICE TARGET TO 1480 (1357) PENCE - 'OVERWEIGHT'
----------
UBS RAISES CLOSE BROTHERS PRICE TARGET TO 1420 (1340) PENCE - 'NEUTRAL'
----------
UBS CUTS FENNER PRICE TARGET TO 480 (500) PENCE - 'BUY'
----------
JEFFERIES CUTS FENNER PRICE TARGET TO 490 (505) PENCE - 'BUY'
----------
UBS RAISES KAZAKHMYS PRICE TARGET TO 300 (210) PENCE - 'NEUTRAL'
----------
UBS CUTS N BROWN TO 'SELL' ('NEUTRAL') - TARGET 535 (565) PENCE
----------
UBS CUTS PREMIER FARNELL PRICE TARGET TO 235 (240) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS RIGHTMOVE TO 'BUY' ('CONVICTION BUY LIST')
----------
GOLDMAN CUTS BARRATT DEVELOPMENTS TO 'NEUTRAL' ('BUY')
----------
GOLDMAN RAISES REDROW TO 'BUY' ('NEUTRAL')
----------
DEUTSCHE BANK CUTS GO-AHEAD GROUP TO 'HOLD' ('BUY') - TARGET 2100 (1640) PENCE
----------
DEUTSCHE BANK RAISES ESURE GROUP PRICE TARGET TO 313 (300) PENCE - 'BUY'
----------
CANACCORD CUTS ESURE GROUP PRICE TARGET TO 295 (305) PENCE - 'BUY'
----------
CITIGROUP RAISES ESURE GROUP PRICE TARGET TO 294 (291) PENCE - 'BUY'
----------
NOMURA RAISES INCHCAPE PRICE TARGET TO 600 (580) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK RAISES INCHCAPE PRICE TARGET TO 685 (655) PENCE - 'BUY'
----------
INVESTEC CUTS HUNTING TO 'HOLD' ('BUY')
----------
JPMORGAN RAISES MERLIN PRICE TARGET TO 430 (415) PENCE - 'OVERWEIGHT'
----------
JEFFERIES RAISES CAPITAL & COUNTIES PRICE TARGET TO 362 (294) PENCE - 'HOLD'
----------
GOLDMAN RAISES CREST NICHOLSON TO 'CONVICTION BUY LIST' ('BUY')
----------
GOLDMAN RAISES BOVIS HOMES PRICE TARGET TO 1187 (1070) PENCE - 'BUY'
----------
GOLDMAN CUTS SAVILLS PRICE TARGET TO 719 (771) PENCE - 'NEUTRAL'
----------
PANMURE CUTS HIKMA PHARMACEUTICALS TO 'HOLD' ('BUY') - TARGET 1400 (1375) PENCE
----------
MAIN MARKET AND AIM
----------
GOLDMAN RAISES LSL PROPERTY SERVICES PRICE TARGET TO 642 (626) PENCE - 'BUY'
----------
CANACCORD CUTS ROCKHOPPER EXPLORATION PRICE TARGET TO 265 (345) PENCE - 'BUY'
----------
CANACCORD CUTS BROOKS MACDONALD TO 'HOLD' ('BUY') - TARGET 1780 (1620) PENCE
----------
NUMIS RAISES TYMAN PRICE TARGET TO 320 (285) PENCE - 'ADD'
----------
CANACCORD RAISES CAPE PLC PRICE TARGET TO 360 (300) PENCE - 'BUY'
----------
NUMIS CUTS MODERN WATER PRICE TARGET TO 62 (77) PENCE - 'BUY'
----------
PANMURE RAISES PHOENIX IT TO 'BUY' ('HOLD') - TARGET 136 (144) PENCE
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.